The Centre has received a new allocation of NOK 9 million from Stiftelsen Kristian Gerhard Jebsen. The extension makes it possible to continue with important research in immunotherapy and precision medicine. The Centre is led by Professor Ludvig A. Munthe.
The funding goes to two new research projects that will contribute to increased knowledge about early stages of cancer development and new forms of cancer treatment.
TREATme is a network of researchers, from 30 European countries, led by Professor Randi Ulberg. The EU funded the network through the COST Action under Horizon 2020.
Professor Emeritus Bjarne Bogen received the King Olav Vs Prize for Cancer Research, from HM King Harald, at a ceremony in the University Aula on 18 October.
Raquel Bartolomé Casado is awarded the medal for her contribution to new knowledge about immunological memory in the gut. The findings from the doctoral dissertation may be important for the development of oral vaccines and treatment of intestinal diseases in the future.
Increasing vaccine scepticism makes it more difficult to achieve herd immunity. We therefore need vaccines that protect each individual even better. Gunnveig Grødeland is now initiating the EU project VAXPRED.
Professor John Torgils Vaage leads a study that will examine the effect of COVID-19 vaccination in immunocompromised and transplant patients. The study has received funding from the vaccine coalition CEPI.
The FRIMEDBIO-funding will go to six research projects that all reached the top in this call for proposals.
Professor Einar Røshol Heiervang thinks it has been rewarding to do health services research in the CARE project. The collaboration between the researchers and the authorities has contributed to proposals for amendments to the Norwegian Child Welfare Act.
Professor Stein Kaasa and international partners are among the shortlisted candidates for the Cancer Grand Challenges awards.
Exchanges and travels between Nepal and Norway are important parts of the COMENTH project. The pandemic has put a halt to this. Yet, through a partial reallocation of funds and digital solutions, the researchers have managed to implement some of the project’s activities.
The EU project REALMENT will make use of so-called Real World Data (RWD), genetic profiles and artificial intelligence (AI) to increase the quality of treatment for patients with mental disorders.